Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

• Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
• The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
• PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
• 

231. Early Data Show Cancer Progression Associated with Increased Risk of Death in Patients With COVID-19

May 28, 2020 | Clinical Trial

230. The Global Impact of COVID-19 on People with Cancer

May 28, 2020 | Regulatory

229. Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Collaborate to Develop COVID-19 Vaccine using ChaESAR Technology

May 28, 2020 | Collaboration

228. Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate

May 28, 2020 | Clinical Trial

227. IRBM’s Advent Announces Manufacture of 13,000 Doses of Covid-19 Vaccine, for Use in P-II/III Study by the University of Oxford

May 28, 2020 | Clinical Trial

226. ARCA Reports AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy

May 28, 2020 | Collaboration

225. Cordenpharma & Moderna Extend Strategic Manufacturing Services Agreement for Supplying Lipid Excipients To Be Used In mRNA-1273 Against The Novel Coronavirus Sars-Cov-2

May 28, 2020 | Collaboration

224. Cerecor Reports FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS

May 28, 2020 | Clinical Trial

223. PureTech Advances LYT-100 (Deupirfenidone) for Treatment of Serious Respiratory Complications that Persist Following Resolution of COVID-19 Infection

May 28, 2020 | Clinical Trial

222. Orpheris to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients

May 28, 2020 | Clinical Trial

221. EU Launches New COVID-19 Fundraising to Address Concerns Over Equal Access

May 28, 2020 | Regulatory

220. SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel COVID-19 Therapeutic Candidate

May 28, 2020 | Clinical Trial

219. Octapharma USA & BioMatrix Support Research Focused on COVID-19 & Myocardial Dysfunction

May 28, 2020 | Collaboration

218. Oncopeptides Reinitiates Patient Enrollment to the Melflufen Clinical Program Following a Temporary Pause Due to the COVID-19 Pandemic

May 28, 2020 | Clinical Trial

217. Atossa Therapeutics Reports Second COVID-19 Therapeutic Development Program, AT-301 Nasal Spray

May 28, 2020 | Clinical Trial

216. Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial

May 28, 2020 | Clinical Trial

215. CalciMedica Reports Positive Interim Analysis of Trial Evaluating Auxora in Patients with Severe COVID-19 Pneumonia

May 28, 2020 | Clinical Trial

214. European Medicines Regulatory Network Fully Mobilised In Fight Against COVID-19

May 28, 2020 | Regulatory

213. Apellis Initiates P-I/II Study of APL-9 in Patients with Severe COVID-19

May 28, 2020 | Clinical Trial

212. resTORbio Initiates Study Evaluating RTB101 for Reducing the Severity of COVID-19 in Nursing Home Residents

May 28, 2020 | Clinical Trial

211. FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection

May 28, 2020 | Diagnostic

210. African and Global Philanthropists Collaborate to Manufacture COVID-19 Medical Equipment in Africa

May 28, 2020 | Collaboration

209. Siemens Healthineers Now Shipping Worldwide Total Antibody Test and Molecular Test Kit for COVID-19 with Expanded Capacity

May 28, 2020 | Diagnostic

208. GenScript Receives CE Marking for Its Neutralizing Antibody Test Kit of SARS-CoV-2 and COVID-19 Diagnostic Products

May 28, 2020 | Diagnostic

207. Philips Launches Next Generation Wearable Biosensor for Early Patient Deterioration Detection, Including Clinical Surveillance for Covid-19

May 28, 2020 | DigiHealth

206. FDA Provides Promised Transparency for Antibody Tests

May 28, 2020 | Regulatory

205. Abbott Reports Clinical Study Data on ID Now COVID-19 Rapid Test Showing Strong Agreement to Lab-Based Molecular PCR Tests

May 28, 2020 | Diagnostic

204.  Novartis Signs a Manufacturing Agreement with Massachusetts Eye and Ear and Massachusetts General Hospital for AAVCOVID Vaccine Program

May 28, 2020 | Collaboration

203. Roche Initiates P-III REMDACTA Study Evaluating Actemra (tocilizumab) + Remdesivir for Hospitalized Patients with Severe COVID-19 Pneumonia

May 28, 2020 | Clinical Trial

202. Atriva to Initiate P-II Clinical Study Evaluating ATR-002 for Treatment of Patients with COVID-19

May 28, 2020 | Clinical Trial

201. Organicell Reports Positive Results from Compassionate Use of Organicell Flow in Severely Ill COVID-19 Patients

May 27, 2020 | Clinical Trial

200.  Ajinomoto Bio-Pharma Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19

May 27, 2020 | Collaboration

199. Hackensack Meridian Health Finds First Treatment (tocilizumab) to Improve Survival in COVID-19 Patients

May 27, 2020 | Clinical Trial

198. I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome

May 27, 2020 | Clinical Trial

197. Health Canada to Accelerate Access to Health Products for COVID-19

May 27, 2020 | Regulatory

196. Anivive Repurposes GC376 for COVID-19 And Submits Pre-IND to FDA

May 27, 2020 | Regulatory

195. Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine

May 27, 2020 | Collaboration

194. Virna Therapeutics and University of Toronto Announce Licensing of Neutralizing Monoclonal Antibodies to Treat COVID-19

May 27, 2020 | Collaboration

193. ImmunityBio & NantKwest Signs an Agreement for Vaccine Against COVID-19

May 27, 2020 | Collaboration

192. MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

May 27, 2020 | Collaboration

191. PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients

May 27, 2020 | Clinical Trial

190. Moleculin Provides Update on Drug Development for COVID-19

May 27, 2020 | Clinical Trial

189. Aerpio and Quantum Leap Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial to Treat ARDS in COVID-19 Patients

May 27, 2020 | Clinical Trial

188. Glenmark to Initiate P-III Clinical Study Evaluating the Combination Therapy for Hospitalized Patients with COVID-19 in India

May 26, 2020 | Clinical Trial

187. Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

May 26, 2020 | Grant

186. Japan’s MHLW to Approve Avigan for COVID-19 by End of May

May 26, 2020 | Regulatory

185. Apotex Donates Critical Medicines to Combat COVID-19

May 26, 2020 | Grant

184. Selected NHS Patients to Access Remdesivir

May 26, 2020 | Clinical Trial

183. Innovation Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 Infection in a Human Cell Line

May 26, 2020 | Clinical Trial

182. Synairgen Provides Update on Expanded SG016 Trial for Patients with COVID-19

May 26, 2020 | Clinical Trial

181. Eli Lilly and Junshi to Initiate Clinical Trials of COVID-19 Antibody in Q2’2020

May 26, 2020 | Clinical Trial

180. Bayer to Support Harvard Research Study to Evaluate Trust in Science in COVID-19 Pandemic

May 26, 2020 | Collaboration

179. Ceapro Expands its Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

May 26, 2020 | Collaboration

178. EMA calls for High-Quality Observational Research in Context of COVID-19

May 26, 2020 | Regulatory

177. Montefiore and Einstein Test a New Drug Combination to Conquer COVID-19

May 26, 2020 | Clinical Trial

176.  Diffusion Pharmaceuticals Receives Accelerated FDA Response to Proposed TSC COVID-19 Clinical Trial Program

May 26, 2020 | Clinical Trial

175. Algernon Reports Submission of IND to the US FDA for Ifenprodil to Treat COVID-19

May 26, 2020 | Regulatory

174. Co-Diagnostics COVID-19 Test Successfully Used to Identify Coronavirus in Cancer Tissue

May 26, 2020 | Diagnostic

173. Merck to Acquire Themis

May 26, 2020 | Collaboration

172. IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

May 26, 2020 | Collaboration

171. Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate EIDD-2801 Against COVID-19

May 26, 2020 | Collaboration

170. Japan’s AnGes Focuses to Release COVID-19 Vaccine By The End of Year

May 25, 2020 | Clinical Trial

169. Philippines To Take Part in 2 Taiwanese Clinical Trials for COVID-19

May 25, 2020 | Clinical Trial

168. AstraZeneca to Begin Supplying 100M Doses of COVID-19 Vaccine to UK from September

May 25, 2020 | Clinical Trial

167. WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns

May 25, 2020 | Regulatory

166. BARDA Funds $1B to AstraZeneca for Research and Development of Novel COVID-19 Vaccine

May 22, 2020 | Grant

165. Color Receives FDA Emergency Use Authorization for COVID-19 Test Using Isothermal Amplification

May 21, 2020 | Diagnostic

164. Vayyar Collaborate with Meditemi to Detect Early Stage COVID-19 Symptoms in Under 10 Seconds

May 21, 2020 | Collaboration

163. Pathnostics Launches COVID-19 PCR Laboratory Test Designed to Detect Acute Infection

May 21, 2020 | Launch

162. Abbott Releases Interim Clinical Study Data On ID Now COVID-19 Rapid Test Showing Strong Agreement To Lab-Based Molecular PCR Tests

May 21, 2020 | Diagnostic

161.  Britain Signs Agreement with Roche and Abbott for 10M Antibody Tests

May 21, 2020 | Diagnostic

160. AbbVie Reports 26 Nonprofits Selected for the COVID-19 Community Resilience Fund

May 21, 2020 | Grant

159.  ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

May 21, 2020 | Clinical Trial

158.  CalciMedica Reports that FDA Has Strongly Recommended Moving to a Blinded Placebo-controlled Trial with Auxora in Patients with Severe COVID-19 Pneumonia

May 21, 2020 | Clinical Trial

157.  FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

May 21, 2020 | Clinical Trial

156. Amarin Supports Study to Investigate the Effects of Vascepa (Icosapent Ethyl) in The Treatment Of COVID-19

May 21, 2020 | Clinical Trial

155. IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance into Human Clinical Studies

May 21, 2020 | Clinical Trial

154. Montefiore-Einstein Scientists Lead Two Trials of Leronlimab Against COVID-19

May 21, 2020 | Collaborations

153.  Kleo Pharmaceuticals and Celularity Collaborate to Rapidly Develop Allogeneic NK Cell Combination Therapies for COVID-19 and Multiple Myeloma

May 21, 2020 | Collaborations

152. Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks

May 21, 2020 | Collaboration

151. Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19

May 21, 2020 | Collaboration

150. AstraZeneca Receives First Supply Agreement for University of Oxford’s ChAdOx1 nCoV-19 Vaccine Against COVID-19

May 21, 2020 | Collaboration

149.  Health Canada Clears Appili Therapeutics’ P-II Clinical Trial Evaluating Favipiravir as a Prophylactic Agent Against COVID-19 Outbreaks

May 21, 2020 | Clinical Trial

148. Indica Labs, Octo, and Axle Work with NIH to Launch a Global COVID-19 Digital Pathology Repository

May 21, 2020 | Launch

148. Apple and Google Launch COVID-19 Exposure Notification System to Support Health Agencies

May 20, 2020 | DigiHealth

147.  Bio-Techne and Kantaro Biosciences Collaborate to Develop And Scale Production of COVID-19 Serology Test

May 20, 2020 | Clinical Trial

146. Bio-Techne and Kantaro Biosciences Collaborate to Develop And Scale Production of COVID-19 Serology Test

May 20, 2020 | Collaboration

145. Vaxart Reports Selection of its Oral COVID-19 Vaccine Lead Candidate

May 20, 2020 | Clinical Trial

144.  Rising Pharmaceuticals to Support P-II Study of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19

May 20, 2020 | Clinical Trial

143. Atossa Therapeutics Reports In vitro Testing Results of COVID-19 Drug

May 20, 2020 | Clinical Trial

142.  CanSino Biologics and Precision NanoSystems  Collaborate to Co-Develop a COVID-19 RNA Vaccine

May 20, 2020 | Collaboration

141. Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising Candidate for COVID-19

May 20, 2020 | Collaboration

140. Hoth Therapeutics Licenses Novel Peptide COVID-19 Therapeutic

May 20, 2020 | Collaboration

139.  Atea Pharmaceuticals Reports IND Clearance of AT-527 for COVID-19 and $215M Funding

May 20, 2020 | Regulatory and Grant

138. FDA Approves Octapharma’s IND for Severe COVID-19 Patients

May 20, 2020 | Regulatory

137.  KANCERA Initiates P-II Study of KAND567 in COVID-19 Patients

May 20, 2020 | Clinical Trial

136.  INOVIO’s INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

May 20, 2020 | Clinical Trial

135.  Aldeyra Therapeutics to Advance ADX-1612 to Clinical Testing and Provides Update on ADX-629 for COVID-19

May 20, 2020 | Clinical Trial

134. Roche Launches Elecsys Anti-SARS-CoV-2 Antibody Blood Test in the US

May 20, 2020 | Launch

133.  Bharat Biotech and Thomas Jefferson University Pursue a Promising Vaccine Candidate Against COVID-19

May 20, 2020 | Collaboration

132. Avacta and Medusa19 Signs a Distribution Agreement For COVID-19 Antigen Test

May 20, 2020 | Collaboration

131. AstraZeneca is in Discussion with Other Governments to Replicate UK Vaccine Deal

May 19, 2020 | Collaboration

130. Covis Initiates P-III Clinical Trial of Alvesco (ciclesonide) Inhaler for the Treatment of COVID-19

May 19, 2020 | Clinical Trial

129.  Sandoz Responds to Increased Demand for Antibiotics and Other Essential Medicines for Patients Amid COVID-19

May 19, 2020 | Pharma

128.   XORTX Provides Update Regarding XRx-008 for ADPKD and XRx-101 for COVID-19 Programs

May 19, 2020 | Clinical Trial

127.  St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19

May 19, 2020 | Collaboration

126.  Natco Donates Chloroquine for International Study to Prevent COVID-19

May 19, 2020 | Grant

125. Be The Match BioTherapies and NantKwest Collaborate to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths

May 19, 2020 | Collaboration

124.  NIH-funded Study to Investigate Pregnancy Outcomes Resulting from COVID-19 Pandemic

May 19, 2020 | Grant

123. FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response

May 19, 2020 | Regulatory

122. Arch Biopartners Expands the Primary Endpoint of its Phase II Trial to Include Prevention of Multiple Organ Injuries in Patients with COVID-19

May 19, 2020 | Clinical Trial

121.  Adjuvance Technologies Reports NIH Funding for COVID-19 Vaccine Research

May 19, 2020 | Grant

120.  Oragenics and Aragen Bioscience Enter into an Agreement to Accelerate Development of TerraCoV2 Against COVID-19

May 18, 2020 | Diagnostic

119. GeneME Develops On-Premise FRANKD Mouth Swab Test for COVID-19

May 18, 2020 | Diagnostic

118. Quidel’s Lyra Direct Sars-Cov-2 Assay Receives Emergency Use Authorization and CE Mark For Molecular Detection Of Covid-19, Without Extraction Step

May 18, 2020 | Diagnostic

117.  GC Pharma to Provide Covid-19 Treatment for Free

May 18, 2020 | Grant

116. NantKwest Reports FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19

May 18, 2020 | Regulatory

115.  Bonus BioGroup Reports Successful Treatment of Acute Pneumonia in Preclinical COVID-19 Model

May 18, 2020 | Clinical Trial

114.  Global Regulators Work Towards Alignment on Policy Approaches and Regulatory Flexibility During COVID-19

May 18, 2020 | Regulatory

113. EMA to Grant Initial Authorization to Gilead’s Remdesivir for COVID-19 in Coming Days

May 18, 2020 | Regulatory

112. Moderna Reports Positive Interim P-I Data of mRNA-1273 Against COVID-19

May 18, 2020 | Clinical Trial

111. Health Canada Approves First Clinical Trial for Potential COVID-19 Vaccine

May 17, 2020 | Regulatory

110.  UK’s Government to Invest £84M for Boosting COVID-19 Vaccine Program

May 17, 2020 | Grant

109. Leading BioSciences Receives IND Clearance for Phase 2 COVID-19 Study

May 15, 2020 | Regulatory

108. Can-Fite Announces Pre-IND Submission to US FDA for Piclidenoson in the Treatment of COVID-19 Infected Patients with Moderate-to-Severe Symptoms

May 15, 2020 | Regulatory

107. Tech Mahindra Leverages AI for Potential COVID-19 Therapeutic Drugs

May 15, 2020 | DigiHealth

105. Algernon Reports Submittion for Ethics Approval of its P-IIb/III Human Study of Ifenprodil for COVID-19

May 15, 2020 | Regulatory

104. Mirror Biologics and Immunovative Therapies Announce Publication 0f The Technical Rationale for Development of A Universal Anti-Viral Vaccine Targeted To Protect Adults From COVID-19

May 15, 2020 | Collaboration

103. Avacta Develops SARS-COV-2 Neutralising Affimer Reagents for COVID-19

May 15, 2020 | Diagnostic

102. ImmuPharma Porvides Updates on its Activities Against Covid-19 with Lupuzor and Ureka

May 14, 2020 | Clinical Trial

101. Kaleido Initiates Controlled Clinical Study of KB109 in Outpatients with Mild-to-Moderate COVID-19

May 14, 2020 | Clinical Trial

100.  Relief Therapeutics and NeuroRx Report Final Manufacturing Validation of RLF-100 for P-IIb/III Clinical Study in Patients with COVID-19 Associated Acute Respiratory Distress Syndrome

May 14, 2020 | Clinical Trial

98. AIM ImmunoTech Report the US FDA Authorization for First Human Ampligen Study in COVID-19 Patients with Cancer

May 14, 2020 | Regulatory

97. NIH Initiates Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

May 14, 2020 | Clinical Trial

96. Enzychem Initiates P-II Study for EC-18 in Preventing ARDS Due to Coronavirus Pneumonia

May 14, 2020 | Clinical Trial

95. Abivax Receives ANSM and Ethics Committee clearance to Evaluate ABX464 in P-IIb/III Study for COVID-19

May 14, 2020 | Clinical Trial

94. Danish Team of Researchers to Test Treatment of Critically Ill Patients Suffering from COVID-19

May 14, 2020 | Clinical Trial

93. Sanofi’s COVID-19 Vaccine to be Available Globally

May 14, 2020 | Clinical Trial

92. Gilead Donates Remdesivir to Japan

May 14, 2020 | Grant

91.  Health Groups Ask India To Rescind Gilead’s Patents For Remdesivir

May 14, 2020 | Regulatory

90. Immunic Receives German Health Authority’s Approval to Initiate a P-II Clinical Trial of itsv IMU-838 in COVID-19 Patients

May 13, 2020 | Regulatory

89. Purdue-Developed Nanomaterial Significantly Enhances Potential COVID-19 Therapeutic

May 13, 2020 | Clinical Trial

88. Roivant Provides Updates for Pivotal BREATHE Study Evaluating Gimsilumab in COVID-19 Patients for the Prevention of Acute Respiratory Distress Syndrome

May 13, 2020 | Clinical Trial

87. Fluxergy Announces $30M to Expand Manufacturing Capacity of Its One-hour POC Diagnostic Testing System in Response to COVID-19

May 13, 2020 | Grant

86. NEOVII Collaborates with Tel Aviv University to Develop Novel COVID-19 Vaccine

May 13, 2020 | Collaboration

85.  FDA Permits Use of Aidoc’s AI Algorithms to Detect and Prioritize Incidental CT Findings Associated With COVID-19

May 12, 2020 | Regulatory

84. Vitagene Launches the First FDA Authorized Saliva Based “Zero Contact” COVID-19 At Home Test

May 12, 2020 | Diagnostics

83. Quidel’s Sofia 2 SARS Antigen FIA Receives the US FDA’s EUA as the First Antigen Test for Rapid Detection of COVID-19

May 12, 2020 | Diagnostics

82. MedTek21 and AccessDx  Reports the Availability of COVID-19 Testing Solution

May 12, 2020 | Diagnostics

81. Glenmark Initiates P-III Clinical Study of Favipiravir for COVID-19 Patients in India

May 12, 2020 | Clinical trial

80. FDA Takes New Actions to Accelerate Development of Novel Treatment Options for COVID-19

May 12, 2020 | Regulatory

79. Nascent Biotech and Manhattan BioSolutions Collaborate to Advance Vaccine Discovery and Development for COVID-19

May 12, 2020 | Collaboration

78. COVID-19 Therapeutics Accelerator Grants $3M to MHI Research Institute for its ColCorona COVID-19 Clinical Trial

May 12, 2020 | Grant

77. GreenLight to Raises $17M to Accelerate Large-Scale Manufacturing of COVID-19 vaccines

May 12, 2020 | Grant

76.  Veru to Initiate P-II Study of VERU-111 to Combat COVID-19

May 12, 2020 | Clinical Trial

75. Moderna’s mRNA-1273 Receives the US FDA’s Fast Track Designation to Treat COVID-19

May 12, 2020 | Regulatory

74.  Gilead Collaborates with Generics Makers to Supply Remdesivir in 127 Countries

May 12, 2020 | Collaboration

73. GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy Exchange for Patient Advocates

May 12, 2020 | Collaboration

72. FDA Expedites Clearance of Caption Health Ultrasound Software to Aid Frontline Healthcare Workers in Fight Against COVID-19 Pandemic

May 12, 2020 | Regulatory

71. The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19

May 12, 2020 | Collaboration

70. COVID-19 Patients Cared for Using EarlySense’s Contact-free Continuous Monitoring Solution at Leading Hospital in the Netherlands

May 12, 2020 | Diagnostics

74. Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France

May 11, 2020 | Collaboration

69. Glenmark introduces 3-in-1 inhaler therapy for COPD in India, promising reduction in risk of severe attacks and improvement in lung function

May 11, 2020 | Diagnostics

68. Abbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity™ i System

May 11, 2020 | Diagnostics

67.Themis collaborates with ABL Europe to manufacture its SARS-CoV-2 Vaccine Candidate in France

May 11, 2020 | Collaboration

66.  KC Wearable Announces Major Partnerships with European Authorities to Combat COVID-19

May 11, 2020 | Collaboration

65. Kiniksa Reports Data for Mavrilimumab in COVID-19 Pneumonia and Hyperinflammation and for Vixarelimab in Diseases Characterized by Chronic Pruritus

May 11, 2020 | Clinical Trial

64. Sorrento Collaborates with Mount Sinai Health System to Develop COVI-SHIELD Antibody Cocktail Targeting COVID-19 

May 08, 2020 | Collaboration

63. GSK to Evaluate Otilimab for Treating Pulmonary Disease Associated with COVID-19

May 07, 2020 | Clinical Trial

62. CoVIg-19 Plasma Alliance to Initiate Clinical Study Evaluating Hyperimmune Therapy for COVID-19 by Summer 2020

May 07, 2020 | Collaboration

61. Gilead’s Veklury (remdesivir) Receives MHLW’s Approval for Patients with Severe COVID-19 in Japan

May 07, 2020 | Regulatory

60. Moderna Anticipates the Initiation of P-III Study of mRNA-1273 for COVID-19 by Early Summer

May 07, 2020 | Clinical Trial

59. Tonix Pharmaceuticals Collaborates with the University of Alberta to Develop Novel Horsepox-Based Vaccines for the Prevention of COVID-19

May 07, 2020 | Collaboration

58. Enlivex Reports Initiation of P-II Clinical Trial of Allocetra in COVID-19 Patients

May 07, 2020 | Clinical Trial

57. NIH-Sponsored COVID-19 Clinical Trial Begins at The Lundquist Institute

May 07, 2020 | Clinical Trial

56. PARI’s Nebulizer Used in the Study with Pulmotect’s Inhaled PUL-042 for COVID-19

May 07, 2020 | Clinical Trial

55. FDA Continues to Combat Fraudulent COVID-19 Medical Products

May 07, 2020 | Regulatory

54. Vanderbilt University Collaborates with IDBiologics to Develop Breakthrough Medicines for COVID-19

May 07, 2020 | Collaboration

53. Fraunhofer Research Consortium iCAIR Uses Synergies to Develop therapies Against COVID-19

May 07, 2020 | Collaboration

52. Euroimmun’s Serology Test Receives the US FDA’s EUA To Identify COVID-19 Antibodies

May 07, 2020 | Diagnostic

51. Polar Pak to manufacture face shields for Health Canada to Combat COIVD-19

May 06, 2020 | Pharma

50. AB Science Initiates P-II Study Evaluating Masitinib In Combination with Isoquercetin For The Treatment of COVID-19

May 06, 2020 | Clinical Trial

49. Humanigen Reports First Patients Dosing in Phase III Study with Lenzilumab with COVID-19

May 06, 2020 | Clinical Trial

48. Adimmune’s Vaccine Requires Further Testing to Initiate Clinical Testing for COVID-19

May 06, 2020 | Clinical Trial

47. CSL Behring Initiates the Development of Plasma Treatment from Recovered COVID-19 Patients

May 06, 2020 | Clinical Trial

46. Relief Therapeutics’ Aviptadil Enters FDA Trial to Treat COVID-19-Induced Acute Respiratory Distress

May 06, 2020 | Clinical Trial

45. Laurent Receives Health Canada’s Approval to Initiate Clinical Study Evaluating LAU-7b for COVID-19

May 06, 2020 | Regulatory

44. Mesoblast Reports First Patient Dosing in P-II/III Study with Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

May 06, 2020 | Clinical Trial

43. Gilead Sciences to Expand Global Supply of Remdesivir

May 06, 2020 | Clinical Trial

42. Bavarian Nordic Collaborates with AdaptVac to Advance COVID-19 Vaccine Program

May 06, 2020 | Collaboration

41. Regeneron Anticipates the Initiation of Clinical Study for its COVID-19 Antibody Cocktail in June

May 05, 2020 | Clinical Trial

40. CohBar To Target COVID-19 Associated ARDS with its Apelin Receptor Agonist Peptides

May 05, 2020 | Clinical Trial

39. Athersys Commences Patient Enrollment in P-II/III MACOVIA Study Evaluating MultiStem Cell Therapy for COVID-19 Induced ARDS

May 05, 2020 | Clinical Trial

38. Innovation to Evaluate the Inhibitory Effect of Brilacidin In Patients with COVID-19

May 05, 2020 | Clinical Trial

37. The Israel Institute for Biological Research Completes the Development Phase of COVID-19 Antibody

May 05, 2020 | Clinical Trial

36. NIH to Fund COLCORONA Clinical Study for COVID-19

May 05, 2020 | Grant

35. Diffusion Pharmaceuticals Reports FDA’s  Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS

May 05, 2020 | Regulatory

34. CEPI Expands COVID-19 Vaccine Portfolio Focusing on Speed And Global Manufacturing

May 05, 2020 | Grant

33. Pfizer and BioNTech Report First Patient Dosing with BNT162 in P-I/II Study for COVID-19 in the US

May 05, 2020 | Clinical Trial

32. Bio-Rad Receives the US FDA’s Emergency Use Authorization for its Droplet Digital PCR Test Kit to Detect COVID-19

May 05, 2020 | Diagnostic

31. Bocconi University’s New Research Laboratory on COVID-19

May 05, 2020 | Pharma

30. EMA Fast-Tracks Development and Approval Of Medicines And Vaccines for COVID-19

May 04, 2020 | Regulatory

29. Arcturus Therapeutics and Catalent Collaborate to Manufacture mRNA-Based COVID-19 Vaccine

May 04, 2020 | Collaboration

28. NanoViricides Signs Confidential Disclosure Agreement with International Pharmaceutical Company to Explore Collaborating on its COVID-19 Program

May 04, 2020 | Collaboration

27. FDA Approves 54 Emergency INDs for Leronlimab to Treat COVID-19

May 04, 2020 | Clinical Trial

26. FDA Approves 54 Emergency INDs for Leronlimab to Treat COVID-19

May 04, 2020 | Regulatory

25. Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Ab Targeting COVID-19

May 04, 2020 | Collaboration

24. CARE to Conduct Clinical Studies For Primary & Secondary Prophylaxis to Reduce COVID-19 Hospitalizations

May 04, 2020 | Clinical Trial

23. Applied DNA and Takis Biotech Produces Neutralizing Antibodies Against SARS-CoV-2 Following DNA Vaccination in Animals

May 04, 2020 | Clinical Trial

22. Vir and Alnylam Anticipate the Initiation of Clinical Study Assessing VIR-2703 By the Year End

May 04, 2020 | Clinical Trial

21. Lilly and Junshi Collaborate to Co-Develop Antibody Therapies for the Treatment of COVID-19

May 04, 2020 | Collaboration

20. Co-Diagnostics Reports Government Approvals and Increased Orders for COVID-19 Test Kits

May 04, 2020 | Diagnostic

19. Aridis Enrolls its First COVID-19 Patient in Ongoing P-III AR-301 Study in Ventilator Associated Pneumonia

May 04, 2020 | Clinical Trial

18. MHLW Expedites the Reviews of Gilead’s Remdesivir to Treat Patients with COVID-19 in Japan

May 03, 2020 | Regulatory

17. Roche Receives FDA’s Emergency Use Authorization for its Elecsys to Detect COVID-19

May 03, 2020 | Diagnostic

16. Bravado Health Collaborates with K-Rain to Screen Employees for COVID-19

May 01, 2020 | Collaboration

15. NASA’s Ventilators Receives the UD FDA’s Emergency Use Authorization  

May 01, 2020 | Regulatory

14. Glenmark Receives DCGI’s Approval to Evaluate Favipiravir for COVID-19 Patients in India

May 01, 2020 | Regulatory

13. Gilead’s Remdesivir Receives the US FDA’s Emergency Use Authorization for the Treatment of COVID-19

May 01, 2020 | Regulatory

12. Moderna Signs a Ten-Year Worldwide Agreement with Lonza to Manufacture mRNA-1273 Against COVID-19

May 01, 2020 | Collaboration

11. Health Canada to Assess the Role Convalescent Plasma for Treating COVID-19

May 01, 2020 | Regulatory

10. PROMETRIKA and Karyopharm Collaborated to Evaluate XPOVIO in Hospitalized Patients with Severe COVID-19.

May 01, 2020 | Clinical Trial

9. EvergreenHealth to Initiate Next Phase 0f Clinical Research Evaluating Remdesivir As a Potential Treatment For COVID-19

May 01, 2020 | Clinical Trial

8. Astellas Pharma Support Solutions Addressing Evolving Patient Needs During COVID-19

May 01, 2020 | Pharma

7. WHO says COVID-19 emergency declaration gave world “enough time”

May 01, 2020 |Regulatory

6. NICE Publishes Rapid Guidelines for COVID-19 Pandemic

May 01, 2020 |Regulatory

5. EvergreenHealth to Initiate Next Phase 0f Clinical Research Evaluating Remdesivir As a Potential Treatment For COVID-19

May 01, 2020 | Clinical Trial

4. LLNL’s Machine Learning Platform Generates Novel Covid-19 Antibody Sequences For Experimental Testing

May 01, 2020 | DigiHealth

3. Husco-Led Consortium Develops Breakthrough Face Mask for Frontline Healthcare Professionals

May 01, 2020 | Pharma

2. Centene And Quest Diagnostics Collaborate To Increase Access To COVID-19 Testing

May 01, 2020 | Diagnostic

1. Hologic to Launch Its Second High-Throughput Molecular Assay for COVID-19

May 01, 2020 | Launch

Related Article: Insights+: COVID-19 Healthcare News Monthly Updates – November 2020